Overview

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
0
Participant gender:
All
Summary
To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Altamash Institute of Dental Medicine
Treatments:
Pentoxifylline
Triamcinolone
Vitamin E
Criteria
Inclusion Criteria:

- Patients with clinically diagnosed OSMF who have not undergone any treatment of OSMF
in past

- Patients willing to quit their tobacco chewing habit, gutkha areca nut smoking

- Patients who are ready to attend regular follow-ups

Exclusion Criteria:

- Patients who have undergone any treatment for OSF in past

- Patients with any evidence of cardiac, gastrointestinal, kidney, metabolic disorders,
pregnant and lactating women's

- Patients with any co-existing disorder of the orofacial region other than OSF which
may interfere with the study protocol